Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type ...
The 'fit and active' lad from Preston couldn't believe his diagnosis at first as he 'felt fine' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results